Healthcare

Fertility Market is set to record 7.4% CAGR by 2030

Fertility Market size is expected to grow Usd 47.9 bn by 2030 at a CAGR of 4.7% over the forecast period 2021 – 2030.

A new study on the global Fertility market has been published by Precedence Research. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global Fertility market. The study offers valuable information about the global Fertility market to illustrate how the market would grow during the forecast period 2021-2030. The report provides the value and volume of the global Fertility market for the period 2021–2030, considering 2019 as the base year and 2030 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.

Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global Fertility market during the forecast period.

Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1202

An extensive analysis on business strategies of leading market players is also featured in study on the global Fertility market. This can help readers understand principal factors to foresee growth in the global Fertility market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.

The report also delves into the competition landscape of the global Fertility market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.

Key Players

  • Boston IVF Fertility Clinic
  • INVO Bioscience
  • San Diego Fertility Center
  • Celmatix
  • FUJIFILM IRVINE SCIENTIFIC
  • Carolinas Fertility Institute
  • Progyny Inc.
  • Cook Medical
  • LifeGlobal Group (Cooper Surgical)

Key Questions Answered in Fertility Market Study

– What are the key factors influencing the Fertility market in each region?

– What will be the CAGR of the global Fertility market between 2017 and 2030?

– What is the future scope and changing trends in technologies in the global Fertility market?

– Which factors will impede the growth of the global Fertility market during the forecast period?

– Which are the leading companies in the global Fertility market?

– Which region is set to expand at the fastest CAGR during the forecast period?

– What is the volume (Units) of different Fertility across all regions during the forecast period?

– Which segment will have the highest revenue globally in 2030 and which segment will expand at the fastest CAGR during the forecast period?

Get Customization on this Research Report@ https://www.precedenceresearch.com/sample/1202

Research Methodology

A unique research methodology has been utilized by precedence research to conduct a comprehensive research on the growth of the global Fertility market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the production of the global Fertility market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from Fertility industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making precedence research estimates on the future prospects of the global market more reliable and accurate.

Segmentation

By Offering

  • Assisted Reproductive Technology
      • IVF
      • Artificial Insemination
      • Surrogacy
      • Others
  • Fertility Drugs
      • Gonadotropin
      • Anti-estrogen
      • Others
  • Others

By End user

  • Fertility Clinics
  • Hospitals
  • Clinical Research Institutes

By Geography

  • North America
      • U.S.
      • Canada
  • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
  • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
  • Latin America
      • Brazil
      • Rest of Latin America
  • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Fertility Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Fertility Market

5.1. Covid-19: fertility Industry Impact
5.2. fertility Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and fertility Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for fertility Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Fertility Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Declining fertility rates across the globe
6.1.1.2. Rising number of fertility clinics worldwide, coupled with technological advancements
6.1.2. Market Restraints
6.1.2.1. High procedural cost of assisted reproductive techniques in developed markets
6.1.3. Market Opportunities
6.1.3.1. Use of fertility treatment options by single parents and same-sex couples

Chapter 7. Global Fertility Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. fertility Market Revenue by Market Players (2017 – 2020)
7.1.1.2. fertility Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Fertility Market, By Offering

8.1. fertility Market, by Offering, 2017-2030
8.1.1. Assisted Reproductive Technology
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.1.2. IVF
8.1.1.3. Market Revenue and Forecast (2017-2030)
8.1.1.4. Artificial Insemination
8.1.1.5. Market Revenue and Forecast (2017-2030)
8.1.1.6. Surrogacy
8.1.1.7. Market Revenue and Forecast (2017-2030)
8.1.1.8. Others
8.1.1.9. Market Revenue and Forecast (2017-2030)
8.1.2. Fertility Drugs
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.2.2. Gonadotropin
8.1.2.3. Market Revenue and Forecast (2017-2030)
8.1.2.4. Anti-estrogen
8.1.2.5. Market Revenue and Forecast (2017-2030)
8.1.2.6. Others
8.1.2.7. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Fertility Market, By End user

9.1. fertility Market, by Grade, 2017-2030
9.1.1. Fertility Clinics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Clinical Research Institutes
9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Fertility Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Offering (2017-2030)
10.1.2. Market Revenue Forecast by End-user(2017-2030)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2017-2030)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2017-2030)
10.2. Europe
10.2.1. Market Revenue Forecast by Offering (2017-2030)
10.2.2. Market Revenue Forecast by End-user (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2017-2030)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2017-2030)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Offering (2017-2030)
10.3.2. Market Revenue Forecast by End-user (2017-2030)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2017-2030)
10.4. LATAM
10.4.1. Market Revenue Forecast by Offering (2017-2030)
10.4.2. Market Revenue Forecast by End-user (2017-2030)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2017-2030)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2017-2030)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Offering (2017-2030)
10.5.2. Market Revenue Forecast by End-user (2017-2030)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2017-2030)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2017-2030)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2017-2030)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2017-2030)

Chapter 11. Company Profiles

11.1. Boston IVF Fertility Clinic
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2017-2020)
11.1.4. Recent Developments and Strategies
11.2. INVO Bioscience
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2017-2020)
11.2.4. Recent Developments and Strategies
11.3. San Diego Fertility Center
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2017-2020)
11.3.4. Recent Developments and Strategies
11.4. Celmatix
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2017-2020)
11.4.4. Recent Developments and Strategies
11.5. FUJIFILM IRVINE SCIENTIFIC
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2017-2020)
11.5.4. Recent Developments and Strategies
11.6. Carolinas Fertility Institute
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2017-2020)
11.6.4. Recent Developments and Strategies
11.7. Progyny Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2017-2020)
11.7.4. Recent Developments and Strategies
11.8. Cook Medical
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2017-2020)
11.8.4. Recent Developments and Strategies
11.9. LifeGlobal Group (Cooper Surgical)
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2017-2020)
11.9.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Get Full Access of this Research Report, Click here@ https://www.precedenceresearch.com/checkout/1202

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog:https://precedenceresearchreport.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

precedenceresearchreports

Recent Posts

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size US$ 4.02 Billion by 2030

The enzyme-linked immunosorbent assay (ELISA) testing market valued at USD 1.63 billion in 2020 and…

3 years ago

Healthcare Distribution Market to Garner Growth 7.8% by 2030

The Healthcare Distribution Market valued at USD 810 billion in 2020 and predicted to hit…

3 years ago

Wollastonite Powder Market Size, Growth, Trends | Industry Report, 2030

The Wollastonite Powder market is anticipated to grow at a CAGR of nearly 8.1% during…

3 years ago

Fruit Preparation for Dairy Market Size, Growth, Trends | Industry Report, 2030

The Fruit Preparation for Dairy market is anticipated to grow at a CAGR of nearly…

3 years ago

Third-party Logistics Market Size, Growth, Trends | Industry Report, 2030

The Third-party Logistics market is anticipated to grow at a CAGR of nearly 8.3% during…

3 years ago

Intelligent Transportation System Market Size, Growth, Trends | Industry Report, 2030

The Intelligent Transportation System market is anticipated to grow at a CAGR of nearly 47.8%…

3 years ago